Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review.

ABSTRACT:

Background

Breast cancer related lymphedema (BCRL) is a prevalent complication secondary to cancer treatments which significantly impacts the physical and psychological health of breast cancer survivors. Previous research shows increasing use of low level laser therapy (LLLT), now commonly referred to as photobiomodulation (PBM) therapy, for BCRL. This systematic review evaluated the effectiveness of LLLT (PBM) in the management of BCRL.

Methods

Clinical trials were searched in PubMed, AMED, Web of Science, and China National Knowledge Infrastructure up to November 2016. Two reviewers independently assessed the methodological quality and adequacy of LLLT (PBM) in these clinical trials. Primary outcome measures were limb circumference/volume, and secondary outcomes included p

SUBMITTER: Baxter GD 

PROVIDER: S-EPMC5719569 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature